Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide and Rabeprazole for Naproxen-Induced Gastric Lesions
NCT03658473Phase 3Completed
- Sponsor
- Galeno Research Center
- Start
- Nov 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rebamipide in gastric lesion, sponsored by Galeno Research Center. Started Nov 2014; status: completed.
02
Drugs
rebamipide
03
Conditions
gastric lesion
Beyond the preview
Go deeper on NCT03658473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658473.